Portfolio company
Deep MedChem
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
Valence Discovery
This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
